HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Brown, A. P. Articles by Rocklin, R. E. Search for Related Content PubMed Articles by Brown, A. P. Articles by Rocklin, R. E.

Human Leukocyte Inhibitory Factor (LIF): Two Distinct Molecular Species¹

From the Department of Medicine, Harvard Medical School, Robert B. Brigham Hospital, Boston, Massachusetts 02120

Abstract

Human leukocyte inhibitory factor or LIF was generated in vitro by stimulating blood lymphocytes with concanavalin A (Con A). The control and Con A active supernatants were partially purified by gel filtration on Sephadex G-100. The fraction containing LIF (68,000 daltons) activity was then subjected to isoelectric focusing (pH 3 to 10 ampholines) in a sucrose gradient. Two LIF activities were reproducibly recovered by this procedure. One molecular form was found to have an isoelectric point of approximately pH 5.0 and the other approximately pH 8.5. Both molecular species were rechromatographed on Sephadex G-75 and found to have the same apparent m.w. (68 to 75,000). Furthermore, the biologic activity of both factors was destroyed after treatment with diisopropylphosphofluoridate, suggesting that they may be esterases.

Footnotes

¹ This work was supported by United States Public Health Service Grant AI-11729 and was presented in part at the annual meeting of the American Association of Immunologists, Atlanta, Georgia, June 4 to 8, 1978.